Market access

Innovative access and pricing solutions

Our specialist market access team supports the world’s leading pharmaceutical, biotech and device manufacturers in market access, pricing and reimbursement. We provide our clients with the insights and recommendations they need to develop the value strategy for their technologies and optimise their revenues

Our portfolio of services include:

Portfolio planning & optimisation

Portfolio planning & optimisation

A successful portfolio strategy sets direction for the future and maximises value. We will help you to plan the strategic management of your product portfolio, enabling you to make the right investment decisions, optimise value, and allocate the most profitable use of resources.

View a case study

Pricing and reimbursement

Pricing and reimbursement

Strategic pricing is essential to maximising revenue and achieving long-term organisational results. Our market insights will help to develop pricing and reimbursement strategies that reflect, maintain, and enhance the value of your assets over their lifetime.

View a case study

Landscape assessment

Landscape assessment

A comprehensive landscape assessment is vital for identifying the access opportunities and challenges for your product. We will assess the current and future treatment, pricing, and reimbursement landscape to ensure that your market access strategies are underpinned by high-value insights.

View a case study

Product profile evaluation

Product profile evaluation

We test and develop target product profiles with experts payers and KOLs to assess their market access potential. We use their feedback on the perceived value of your product to identify evidence gaps, provide guidance on minimum thresholds to achieve reimbursement and input into future development plans. 

View a case study

Payer engagement

Payer engagement

Innovative engagement approaches are invaluable for improving payer relationships. We will develop a range of payer engagement programmes including expert panels, advisory boards, mock negotiations and training sessions to ensure closer proximity with payers and establish long-term trust-based relationships.

View a case study

Emerging market expertise

Emerging market expertise

We conduct payer research in over 50 mature and emerging markets including Brazil, India and China to help you maximise your competitive advantage in the markets offering the best opportunities for growth.


View a case study

Market access resources:

Keeping up with coronavirus Sept 2020

Webinar

Keeping up with the Coronavirus: Monitoring the impact of COVID-19 on the market access landscape.

View

US Flags_rapport

Article

How will COVID-19 affect the financing of healthcare provision across the US?

Find out more

Rectangle 51@2x

Infographic

Selected deals for SARS-CoV-2 vaccines in late stage development.


Download

 
Rachel-Howard-Staff-Profile

Rachel Howard

Director, Market Access

Rachel Howard is a Director in our London office. With over 12 years’ experience working in life sciences, Rachel has extensive experience managing large scale, complex studies, both qualitative and quantitative. Over the course of her career Rachel has lived and worked in London, New York and Singapore, giving her broad global experience spanning three continents and particular emerging markets experience. Rachel has a University Diploma in European Market Access (EMAUD) and focuses on market access and pricing research, with a particular focus on vaccines and infectious diseases. In 2020, she led a multi-client study interviewing over 70 payers, NITAGs and KOLs spanning 8 global markets to evaluate the impact of COVID-19 on market access, and has published a number of thought pieces in this area.